What is the real per-recipient economic value?

$101 million prize purse; per-recipient maximum not established. Award minimum: not published. Dilution/equity: none.

Which jurisdictions and applicants are eligible?

Global teams of individuals or organizations could enter. New entry now requires discretionary late registration and qualification; only qualified semifinalists could submit the April 2026 finals application.

A safe, accessible therapeutic completed in one year or less; Restoration of muscle, cognitive and immune function by at least 10 years in people aged 50–80; Robust clinical and biomarker evidence under finals rules

What burden or follow-on should I expect?

Extensive rules, clinical-study evidence, safety/accessibility requirements, biomarkers and formal platform submissions; this is a high-burden prize, not a grant for ordinary operating costs. Milestone and final prizes within one competition; no automatic follow-on grant.

XPRIZE Healthspan

$101 million prize purse; per-recipient maximum not established · XPRIZE / Hevolution Foundation

XPRIZE Healthspan is a prize programme from XPRIZE / Hevolution Foundation for Teams worldwide that register under the competition rules and can demonstrate an intervention restoring muscle, cognition, and immune function in older adults Current status: closed; Seven-year competition, 2023–2030; primary registration is closed and late registration is discretionary rather than an open deadline. Award economics: $101 million prize purse; per-recipient maximum not established; dilution/equity: none.

Tier 1prizeglobalhealthnon-dilutive

Apply Official site Open in the live directory

Key facts

Funder	XPRIZE / Hevolution Foundation
Amount	$101 million prize purse; per-recipient maximum not established
Decision time	Qualification, semifinals, finals application and human study/testing; final award depends on demonstrated functional restoration under the rules.
Eligibility	Global teams of individuals or organizations could enter. New entry now requires discretionary late registration and qualification; only qualified semifinalists could submit the April 2026 finals application.
Restrictions	Extensive rules, clinical-study evidence, safety/accessibility requirements, biomarkers and formal platform submissions; this is a high-burden prize, not a grant for ordinary operating costs. Dilution/equity: none.
Status	closed

Always confirm on the official page before applying — dates and terms change.

Application process

Register a team or request discretionary late registration
Complete qualifying submission and judging
Advance through semifinals
Qualified semifinalists submit a finals application
Run the required study and demonstrate restoration of muscle, cognitive and immune function

Background

XPRIZE / Hevolution Foundation operates XPRIZE Healthspan. The official-source pass separates the currently actionable opportunity from historical cohorts and separates per-recipient value from headline program envelopes. The official page lists first milestone winners announced in May 2025 and a qualified-teams book.

How the application really works

Register a team or request discretionary late registration → Complete qualifying submission and judging → Advance through semifinals → Qualified semifinalists submit a finals application → Run the required study and demonstrate restoration of muscle, cognitive and immune function

Tips

Demonstrate: A safe, accessible therapeutic completed in one year or less
Demonstrate: Restoration of muscle, cognitive and immune function by at least 10 years in people aged 50–80
Demonstrate: Robust clinical and biomarker evidence under finals rules

Watch out for

Current status is closed; do not use an archived form.
Dilution/equity treatment: none.
Extensive rules, clinical-study evidence, safety/accessibility requirements, biomarkers and formal platform submissions; this is a high-burden prize, not a grant for ordinary operating costs.

Track record

The official page lists first milestone winners announced in May 2025 and a qualified-teams book.

Qualified-team and milestone-winner materials are published; no simple acceptance percentage is stated.

Frequently asked questions

Is this opportunity actionable now?: closed. Seven-year competition, 2023–2030; primary registration is closed and late registration is discretionary rather than an open deadline.
What is the real per-recipient economic value?: $101 million prize purse; per-recipient maximum not established. Award minimum: not published. Dilution/equity: none.
Which jurisdictions and applicants are eligible?: Global teams of individuals or organizations could enter. New entry now requires discretionary late registration and qualification; only qualified semifinalists could submit the April 2026 finals application.
How does selection work?: Register a team or request discretionary late registration; Complete qualifying submission and judging; Advance through semifinals; Qualified semifinalists submit a finals application; Run the required study and demonstrate restoration of muscle, cognitive and immune function. Qualification, semifinals, finals application and human study/testing; final award depends on demonstrated functional restoration under the rules.
What appears to win?: A safe, accessible therapeutic completed in one year or less; Restoration of muscle, cognitive and immune function by at least 10 years in people aged 50–80; Robust clinical and biomarker evidence under finals rules
What burden or follow-on should I expect?: Extensive rules, clinical-study evidence, safety/accessibility requirements, biomarkers and formal platform submissions; this is a high-burden prize, not a grant for ordinary operating costs. Milestone and final prizes within one competition; no automatic follow-on grant.

Sources

www.xprize.org/competitions/healthspan — Official active competition, purse, participation, judging target, late registration and finals process (checked 2026-08-10)